Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Classical hematology 1

Conditions

Fanconi Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Gemcitabine 2fludarabine phosphate 1eltrombopag 1SRA737 1Radiotherapy 1Methylprednisolone 1Melphalan 1Enoxaparin 1Cyclophosphamide 1Cisplatin 1Busulfan 1Aspirin 1Antilymphocyte Serum 1Acupuncture Therapy 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × SRA737 × Classical hematology × Clear all
NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
153 enrolled
Classical hematologySarcomaThoracic

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡